These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10741557)

  • 1. Naphthyl ketones: a new class of Janus kinase 3 inhibitors.
    Brown GR; Bamford AM; Bowyer J; James DS; Rankine N; Tang E; Torr V; Culbert EJ
    Bioorg Med Chem Lett; 2000 Mar; 10(6):575-9. PubMed ID: 10741557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinyl aspartyl ketones as inhibitors of caspase-3.
    Isabel E; Black WC; Bayly CI; Grimm EL; Janes MK; McKay DJ; Nicholson DW; Rasper DM; Renaud J; Roy S; Tam J; Thornberry NA; Vaillancourt JP; Xanthoudakis S; Zamboni R
    Bioorg Med Chem Lett; 2003 Jul; 13(13):2137-40. PubMed ID: 12798321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simplified staurosporine analogs as potent JAK3 inhibitors.
    Yang SM; Malaviya R; Wilson LJ; Argentieri R; Chen X; Yang C; Wang B; Cavender D; Murray WV
    Bioorg Med Chem Lett; 2007 Jan; 17(2):326-31. PubMed ID: 17088059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents.
    Sudbeck EA; Liu XP; Narla RK; Mahajan S; Ghosh S; Mao C; Uckun FM
    Clin Cancer Res; 1999 Jun; 5(6):1569-82. PubMed ID: 10389946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JAK protein kinase inhibitors.
    Thompson JE
    Drug News Perspect; 2005 Jun; 18(5):305-10. PubMed ID: 16193102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent transglutaminase inhibitors, dithio β-aminoethyl ketones.
    Ozaki S; Ebisui E; Hamada K; Suzuki AZ; Terauchi A; Mikoshiba K
    Bioorg Med Chem Lett; 2011 Jan; 21(1):377-9. PubMed ID: 21134746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel trifluoromethyl ketones as potent gastric lipase inhibitors.
    Kokotos G; Kotsovolou S; Verger R
    Chembiochem; 2003 Jan; 4(1):90-5. PubMed ID: 12512081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-Keto sulfones as inhibitors of 11beta-hydroxysteroid dehydrogenase type I and the mechanism of action.
    Xiang J; Ipek M; Suri V; Tam M; Xing Y; Huang N; Zhang Y; Tobin J; Mansour TS; McKew J
    Bioorg Med Chem; 2007 Jul; 15(13):4396-405. PubMed ID: 17490884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting JAK3 and BTK tyrosine kinases with rationally-designed inhibitors.
    Vassilev AO; Tibbles HE; DuMez D; Venkatachalam TK; Uckun FM
    Curr Drug Targets; 2006 Mar; 7(3):327-43. PubMed ID: 16515530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of Janus kinase 3 (JAK3) inhibitors.
    Cetkovic-Cvrlje M; Tibbles HE
    Curr Pharm Des; 2004; 10(15):1767-84. PubMed ID: 15180539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine kinase inhibitors. 2. Synthesis of 2,2'-dithiobis(1H-indole-3-alkanamides) and investigation of their inhibitory activity against epidermal growth factor receptor and pp60v-src protein tyrosine kinases.
    Thompson AM; Fry DW; Kraker AJ; Denny WA
    J Med Chem; 1994 Mar; 37(5):598-609. PubMed ID: 7510340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of an aromatic trifluoromethyl ketone as a new warhead for covalently reversible kinase inhibitor design.
    Zhang Z; Wang Y; Chen X; Song X; Tu Z; Chen Y; Zhang Z; Ding K
    Bioorg Med Chem; 2021 Nov; 50():116457. PubMed ID: 34670167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxylated 2-(5'-salicyl)naphthalenes as protein-tyrosine kinase inhibitors.
    Smyth MS; Stefanova I; Horak ID; Burke TR
    J Med Chem; 1993 Oct; 36(20):3015-20. PubMed ID: 8411019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Janus kinase 3 down-regulates lipopolysaccharide-induced IL-1 beta-converting enzyme activation by autocrine IL-10.
    Kim HJ; Hart J; Knatz N; Hall MW; Wewers MD
    J Immunol; 2004 Apr; 172(8):4948-55. PubMed ID: 15067075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3,5,6-Trisubstituted naphthostyrils as CDK2 inhibitors.
    Liu JJ; Dermatakis A; Lukacs C; Konzelmann F; Chen Y; Kammlott U; Depinto W; Yang H; Yin X; Chen Y; Schutt A; Simcox ME; Luk KC
    Bioorg Med Chem Lett; 2003 Aug; 13(15):2465-8. PubMed ID: 12852944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 6. Trans-6-[2-(substituted-1-naphthyl)ethyl(or ethenyl)]-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-ones.
    Prugh JD; Alberts AW; Deana AA; Gilfillian JL; Huff JW; Smith RL; Wiggins JM
    J Med Chem; 1990 Feb; 33(2):758-65. PubMed ID: 2299642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine kinase inhibitors. 4. Structure-activity relationships among N- and 3-substituted 2,2'-dithiobis(1H-indoles) for in vitro inhibition of receptor and nonreceptor protein tyrosine kinases.
    Palmer BD; Rewcastle GW; Thompson AM; Boyd M; Showalter HD; Sercel AD; Fry DW; Kraker AJ; Denny WA
    J Med Chem; 1995 Jan; 38(1):58-67. PubMed ID: 7837241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Janus kinase-3 (JAK3) inhibition: a novel immunosuppressive option for allogeneic transplantation.
    Säemann MD; Zeyda M; Stulnig TM; Böhmig GA; Wekerle T; Hörl WH; Zlabinger GJ
    Transpl Int; 2004 Oct; 17(9):481-9. PubMed ID: 15368094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine kinase inhibitors. 9. Synthesis and evaluation of fused tricyclic quinazoline analogues as ATP site inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor.
    Rewcastle GW; Palmer BD; Bridges AJ; Showalter HD; Sun L; Nelson J; McMichael A; Kraker AJ; Fry DW; Denny WA
    J Med Chem; 1996 Feb; 39(4):918-28. PubMed ID: 8632415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant inhibition of Janus kinase 3 and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts.
    Behbod F; Erwin-Cohen RA; Wang ME; Trawick BW; Qu X; Verani R; Kahan BD; Stepkowski SM; Kirken RA
    J Immunol; 2001 Mar; 166(6):3724-32. PubMed ID: 11238613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.